CD7 CAR-T cells injection

BIOLOGICAL4 trials

Sponsors

Zhejiang University

Conditions

Aplastic AnemiaBone Marrow Failure SyndromeHematologic DiseasesNeoplasmsSchimke Immuno-osseous Dysplasia

Early Phase 1

CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia

RecruitingNCT06633328

Zhejiang UniversityAplastic Anemia

Start: 2024-10-20End: 2027-10-20Target: 30Updated: 2024-10-09

Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell Sequential Allo-HSCT and Kidney Transplantation in the Treatment of SIOD

RecruitingNCT06769191

Zhejiang UniversitySchimke Immuno-osseous Dysplasia

Start: 2025-01-30End: 2028-01-30Target: 20Updated: 2025-01-20

CD7 CAR-T Cell Sequential Allo-HSCT for Non-malignant Blood and Immune System Diseases

RecruitingNCT06787560

Zhejiang UniversityBone Marrow Failure Syndrome

Start: 2025-01-31End: 2028-01-31Target: 20Updated: 2025-01-22

Phase 1

CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases

RecruitingNCT05827835

Zhejiang UniversityHematologic Diseases, Neoplasms

Start: 2023-04-30End: 2027-04-25Target: 30Updated: 2025-08-13

Related Papers

Interim Phase 1 study of sequential CD7 CAR T-cell therapy and haploidentical HSCT without GVHD prophylaxis in patients with Relapsed/Refractory CD7-positive hematologic malignancies

Blood2025-11-03